Welcome! – Treatment Action Group

white type on red background that says: TAG Update, December 2021, Progress Toward Ending HIV/AIDS, Tuberculosis, and Hepatitis C, help us continue our work in 2022

Banner that reads Tuberculosis Research Funding Trends 2005 - 2020, with two logos that say Stop TB Partnership and TAG Treatment Action Group

image that reads TAG research in action awards, november 16, 2021: thank you! to everyone who made this year's RIAA the best ever

text reads 2021 limited art edition by Nancy Brooks Brody; book marks, 2021, hand painted on 300 lb 100% cotton paper, 16 1/8 by 8 5/8 inches framed; unique multiple of 40, courtesy of the artist

image of the cover of October 2021 TAGline with the title delivering on the promist of long-acting formulatons. cover shows calendar pages labeled with month's names amongst lungs, livers, and AIDs ribbons

Image montage of TAG Limited Art Editions

image that reads Research in Action Awards, November 16, 2021. Red background with white type and TAG in a black circle

Image link to About the COVID-19 Project page

Pipeline Reports

The current ones are all online and available for download now.

January 14, 2022
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).

January 12, 2022
Integration of Viral Hepatitis Prevention and Treatment for People Who Inject Drugs
On February 3, 2022, TAG in collaboration with the International Network of People who Use Drugs (INPUD), Harm Reduction International (HRI), and the World Hepatitis Alliance (WHA), will host this free webinar.

January 11, 2022
Grant Officer
TAG is seeking a dynamic, highly motivated, and organized Grant Officer to support grant and fundraising efforts. This position will report to TAG’s Director of Development, and is a full-time, salaried role. Apply today!

December 22, 2021
Statement from TAG’s HIV Project on FDA’s Approval of Injectable Pre-Exposure Prophylaxis
Statement / Press
Treatment Action Group (TAG) welcomes and celebrates the U.S. Food and Drug Administration’s (FDA) approval of Apretude brand cabotegravir, the first injectable medication for use as pre-exposure prophylaxis (PrEP) to reduce the risk of HIV transmission.

December 16, 2021
2021 TAG Update
Publication
As we look forward to an end of an extremely challenging year—and past four years—we reflect on the remarkable resilience and impact of TAG, even and especially in these dark times.